Grigore Burdea receives 2018 Most Impactful Rehab Tech Award

Professor Grigore Burdea is the recipient of the American Congress of Rehabilitation Medicine's 2018 Most Impactful Rehab Tech Award. The American Congress of Rehabilitation Medicine is the largest conference in the world on research in rehabilitation.  

The award is in recognition of Professor Burdea's work on 21st Century integrative medicine. Professor Burdea is known for his use of therapeutic games to treat the patient from a holistic approach. Most notably, the benefits of Professor Burdea’s research have been demonstrated in a male dementia patient regaining his ability to read within three-weeks of therapy and a fifteen year old stroke patient improving his daily activities completion rate by 30% after a month of therapy.  

Bright Cloud International, a Rutgers startup, is rooted in decades of research Professor Burdea has conducted at the Rutgers CAIP Center and the Tele-Rehabilitation Institute.

Ivan Seskar appointed Chief Technologist, WINLAB

Rutgers University has approved the promotion of Ivan Seskar to the newly created position of Chief Technologist, WINLAB effective 9/24/2018. As Chief Technologist, Ivan will be responsible for leading WINLAB’s technology R&D programs including major new projects such as COSMOS, handling industry/standards outreach and international collaborations, and managing WINLAB’s research/IT infrastructure.

Please join us in congratulating Ivan on this well-deserved promotion, and thanking him for over 25 years of sustained contributions to WINLAB's and ECE's excellence at Rutgers!

HKN Tutoring Night

HKN will be hosting a tutoring night and study session for all ECE undergrads to help prepare for midterms. The event will be from 6:30pm to 8pm in EE203. Come out to study or just to get some homework done!

Umer Hassan and Mehdi Javanmard receive Exploratory Busch Biomedical Grant

Assistant Professors Umer Hassan (PI) and Mehdi Javanmard have received an exploratory Busch Biomedical Grant from the Office of the Vice Chancellor for Research and Innovation, Rutgers-New Brunswick. The grant of $40,000 will support Umer and Mehdi's research on developing a point of care sensor for sepsis stratification. The project titled "Point-of-Care Biochip to Quantify αMβ2, and CD64 Co-expression for Sepsis Stratification" carried out in collaboration with Robert Wood Johnson Medical School will develop a point-of-care microfluidic biochip to quantify WBCs (and differentials), their surface antigen’s expression levels (nCD64) and co-expression of surface-receptors (CD11b/CD18) on neutrophils from whole blood in less than 30 min.

Congratulations Umer and Mehdi!

ECE Research Day


The annual ECE Research Day will be held on Wednesday, November 14, from 12 pm-3 pm in the EE building hallway. The event will be attended by faculty, members of industry, alumni and students. This event is a great opportunity to present your research projects, share your creative ideas, and network with your peers.

Engineering Meets Medicine Meets Global Health

Engineers are essential to our health. From water purification and flood mitigation to surgical equipment and chemotherapy, they contribute across many specialties.

In countries around the world, severe resource limitations can get in the way of health and health care delivery—and the role engineers play can be even more crucial. A pace-setter in this evolving field is Umer Hassan, a new faculty member in the School of Engineering with a joint appointment at Rutgers Global Health Institute. He is pursuing an interdisciplinary set of research initiatives at Rutgers that share a common goal: saving lives, particularly in vulnerable communities.

Engineering Meets Medicine Meets Global Health

Hassan, an assistant professor, is working with colleagues universitywide to apply his electrical and computer engineering expertise—which incorporates personalized medicine, predictive prognostic systems, and infectious disease—to solve pressing global health challenges. One such challenge: sepsis, a life-threatening condition caused by the body’s response to infection. Any kind of infection can potentially lead to sepsis—urinary tract infection, strep throat, influenza—and even routine surgeries create a risk. The human body’s complex response in sepsis can cause tissue damage, organ failure, and death. Sepsis survivors have described their pain as feeling like they were going to die.

In 2017, the World Health Organization identified as a global health priority the urgent need to improve the prevention, diagnosis, and management of sepsis. Hassan is designing a medical device that would bring to a patient’s bedside the capacity to diagnose sepsis—and do so quickly, accurately, inexpensively, and with minimal training required for health care providers.

Inexpensive Device Detects Sepsis Quickly and Accurately

WHO estimates that sepsis causes 6 million deaths worldwide every year, most of which are preventable. In lower- and middle-income countries, there may not even be a trained clinician available to draw a blood sample to test for sepsis, let alone a physician specialist capable of managing such a dynamic, life-threatening condition.

Intervention, by way of innovation, is desperately needed.

Hassan is actively engaged in the global effort to combat sepsis. “We are building an automated device that would cost less than $10 a test and is simple to operate. Many countries’ health systems cannot support large equipment and expensive technologies that require advanced training and knowledge to use,” he says.

Time and accurate diagnoses are critical factors in managing sepsis. Hassan is working across disciplines at Rutgers and with industry partners to identify new biomarkers and create machine-learning algorithms—essentially, artificial intelligence systems—that will “dramatically improve clinicians’ abilities to diagnose as well as predict sepsis,” he says. “Not only in resource-limited settings, but everywhere.”

Hassan’s findings were recently published in the journal Nature Communications, in a co-authored paper titled “A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification.” This spring, he will teach an engineering course in which students will learn to develop applications for global health settings.

Story by Lori Riley for Rutgers Global Health Institute

Photography by Nick Romanenko

Story posted on


Subscribe to Rutgers University, Electrical & Computer Engineering RSS